Deborah A. DeCotis - 30 May 2025 Form 4 Insider Report for Cadre Holdings, Inc. (CDRE)

Reporting relationship: Director
Issuer ticker: CDRE
Reported as of: 30 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2025, 16:49:53 UTC
Prior SEC filing: 20 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Deborah A. DeCotis

Key filing fact

Deborah A. DeCotis filed Form 4 for Cadre Holdings, Inc. (CDRE) on 03 Jun 2025.

Key facts

This page summarizes Deborah A. DeCotis's Form 4 filing for Cadre Holdings, Inc. (CDRE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2025, 16:49.

Change

Previous filing in this sequence was filed on 20 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001177404 Primary reporting owner

DeCotis Deborah A

Relationship: Director
Address: C/O CADRE HOLDINGS, INC., 13386 INTERNATIONAL PKWY, JACKSONVILLE
Signature: /s/ Deborah A. DeCotis
Signature date: 03 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDRE transaction Derivative

Stock Option (right to purchase)

Award

Transaction value: $0
Shares: +16,000
Change %
Price: $0.000000
Shares after: 16,000
Date: 30 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,000
Exercise price: $32.77
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option to purchase shares of Cadre Holdings, Inc. (the "Issuer") common stock, $0.0001 par value per share (the "Common Stock"), was granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,000 shares of the Issuer's Common Stock will vest and become exercisable in four equal consecutive quarterly tranches on each of June 30, 2025, September 30, 2025, December 31, 2025, and March 31, 2026, respectively.